Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
2 Results for "
metabolic dysfunction-related fatty liver disease
" in MedChemExpress (MCE) Product Catalog:
Products (2)
2 Results for "metabolic dysfunction-related fatty liver disease" in MCE Product Catalog:
7
7 Cited Publications
Cat. No.: HY-N0010
CAS No.: 27741-01-1
Category:
Iridoids Terpenoids Plants Other Families Extract Endogenous metabolite Disease Research Fields Cancer
Target:
Cat. No.: HY-162122
CAS No.: 3027045-35-5
Target:
Research Areas:
PPARα/γ agonist 3 (Compound 4) is a dual agonist of PPARα/γ. PPARα/γ agonist 3 has anti-inflammatory activity, significantly reducing inflammatory markers such as IL-6 and MCP-1 on THP-1 macrophages through NF-κB activation. PPARα/γ agonist 3 can be used in the study of metabolic syndrome and metabolic dysfunction-related fatty liver disease (MAFLD) .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
